Simplex Trading’s INmune Bio INMB Stock Holding History
Bought
Maintained
Sold
Other funds holding INMB
Simplex Trading's INMB Position: Q3 2026 in Review
Simplex Trading sold out of INmune Bio (INMB) in Q3 2026, closing a stake of 23 shares — an estimated $47 sold.
Simplex Trading first reported a position in INMB in Q2 2021 and held it in 18 quarters. The position peaked at $334K in Q1 2025. 46 funds tracked by Wall St. Rank hold INMB as of Q3 2026.
- Simplex Trading reported no remaining INmune Bio position as of Q3 2026 after selling out during the quarter.
- Simplex Trading sold 23 INmune Bio shares in Q3 2026, an estimated $47.
- Simplex Trading first reported a position in INmune Bio in Q2 2021 and held it in 18 quarters.
- Simplex Trading's INmune Bio position peaked at $334K in Q1 2025.
- 46 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.
Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.